Amgen’s Surprise Aflibercept Launch Shakes Up US Biosimilars In 2024

As Market Approaches Tenth Anniversary Of First Biosimilars Approval And Launch

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.